1
Total investments
0
Early stage
0
Mid stage
0
Late stage
2y
Years active
Portfolio
0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 5 entries
All (5)
Investments (1)
Founder (2)
2024
Member of the Consultative Working Group of the Investor Protection Standing Committee
Oct 2024
ESMA is an independent EU Authority that was established in 2011. It works closely with the national competent authorities who are members of the European System of Financial Supervision and the other European Supervisory Authorities – the European Banking Authority (EBA) responsible for banking and the European Insurance and Occupational Pensions Authority (EIOPA) responsible for insurance and occupational pensions.
Contact information: https://www.esma.europa.eu/contact-information
2023
Co-founder & co-CEO
2023
Weavers es la primera plataforma inteligente de bienestar financiero diseñada para mejorar la vida de las personas.
Acompañamos a una nueva generación de empresas comprometidas con el bienestar de sus equipos.
2021
Senior Visiting Associate
2021
Founded in 1997, Pan-European VC Earlybird backs exceptional early-stage companies, supporting them through their growth and development phases and providing financial resources, strategic support, plus access to an international network and capital markets.
Through two separate strategies, Earlybird focuses on tech-enabled businesses across software applications, infrastructure, and deep tech, while Earlybird Health focuses on life science breakthroughs accelerated by data-driven analytics and operations. Earlybird also has a pro-bono impact initiative, Vision Lab. With EUR 2.5 billion under management across fund streams and a history of 9 IPOs and 41 trade sales, Earlybird is among Europe’s most established and active venture capital firms.
More information: www.earlybird.com
X: https://x.com/EarlybirdVC
LinkedIn:www.linkedin.com/company/earlybird-venture-capital
Instagram: https://www.instagram.com/earlybirdvc/
2009
2001
Equity Research Analyst
2001
Exane was founded in 1990, on the back of a robust business model built around 3 fundamentals: the world of Equities, Investment and Research. Its expertise consistently wins strong recognition among clients as demonstrated in key investor surveys.
Exane is specialised in two businesses:
- Cash Equities: Research, execution, sale on European equities under the brand name BNP Paribas Exane;
- Structured Solutions: Exane Solutions has developed a complete range of products and services through different pillars: Derivatives Research, structured products, indices, smart execution.
Our 800 employees can now be found spread across 9 sites worldwide, with Paris and London as its main offices.
After a successful 17-year partnership with BNP Paribas, Exane became a subsidiary of BNP Paribas in July 2021.
Similar investors
Co-invested with Natalia
Investor lists
Lists that match Natalia's portfolio
- Startup investors in Germany2,001 investors






